OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 214 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.

Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$310,000,000
-57.5%
11,096
-63.0%
0.01%
-57.1%
Q1 2014$730,000,000
+10328.6%
30,000
+200.0%
0.01%
Q4 2013$7,000,00010,0000.00%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Baker Brothers Advisors 28,439,114$590,396,0003.89%
GREAT POINT PARTNERS LLC 1,196,098$24,831,0003.87%
EMORY UNIVERSITY 196,601$4,081,0002.67%
Ghost Tree Capital, LLC 500,000$10,380,0002.21%
Ghost Tree Capital, LLC 500,000$10,380,0002.21%
NEXTHERA CAPITAL LP 500,000$10,380,0001.99%
Palo Alto Investors LP 1,684,180$34,964,0001.41%
Opus Point Partners Management, LLC 20,828$432,0001.03%
Opaleye Management Inc. 195,000$4,048,0001.03%
GARRISON BRADFORD & ASSOCIATES INC 48,500$1,007,0000.81%
View complete list of ACADIA PHARMACEUTICALS INC shareholders